446 research outputs found
Topological Wilson-loop area law manifested using a superposition of loops
We introduce a new topological effect involving interference of two meson
loops, manifesting a path-independent topological area dependence. The effect
also draws a connection between quark confinement, Wilson-loops and topological
interference effects. Although this is only a gedanken experiment in the
context of particle physics, such an experiment may be realized and used as a
tool to test confinement effects and phase transitions in quantum simulation of
dynamic gauge theories.Comment: Superceding arXiv:1206.2021v1 [quant-ph
Optical lattice quantum simulator for QED in strong external fields: spontaneous pair creation and the Sauter-Schwinger effect
Spontaneous creation of electron-positron pairs out of the vacuum due to a
strong electric field is a spectacular manifestation of the relativistic
energy-momentum relation for the Dirac fermions. This fundamental prediction of
Quantum Electrodynamics (QED) has not yet been confirmed experimentally as the
generation of a sufficiently strong electric field extending over a large
enough space-time volume still presents a challenge. Surprisingly, distant
areas of physics may help us to circumvent this difficulty. In condensed matter
and solid state physics (areas commonly considered as low energy physics), one
usually deals with quasi-particles instead of real electrons and positrons.
Since their mass gap can often be freely tuned, it is much easier to create
these light quasi-particles by an analogue of the Sauter-Schwinger effect. This
motivates our proposal of a quantum simulator in which excitations of
ultra-cold atoms moving in a bichromatic optical lattice represent particles
and antiparticles (holes) satisfying a discretized version of the Dirac
equation together with fermionic anti-commutation relations. Using the language
of second quantization, we are able to construct an analogue of the spontaneous
pair creation which can be realized in an (almost) table-top experiment.Comment: 21 pages, 10 figure
Relativistic quantum mechanics with trapped ions
We consider the quantum simulation of relativistic quantum mechanics, as
described by the Dirac equation and classical potentials, in trapped-ion
systems. We concentrate on three problems of growing complexity. First, we
study the bidimensional relativistic scattering of single Dirac particles by a
linear potential. Furthermore, we explore the case of a Dirac particle in a
magnetic field and its topological properties. Finally, we analyze the problem
of two Dirac particles that are coupled by a controllable and confining
potential. The latter interaction may be useful to study important phenomena as
the confinement and asymptotic freedom of quarks.Comment: 17 pages, 4 figure
Generalized nonreciprocity in an optomechanical circuit via synthetic magnetism and reservoir engineering
Synthetic magnetism has been used to control charge neutral excitations for
applications ranging from classical beam steering to quantum simulation. In
optomechanics, radiation-pressure-induced parametric coupling between optical
(photon) and mechanical (phonon) excitations may be used to break time-reversal
symmetry, providing the prerequisite for synthetic magnetism. Here we design
and fabricate a silicon optomechanical circuit with both optical and mechanical
connectivity between two optomechanical cavities. Driving the two cavities with
phase-correlated laser light results in a synthetic magnetic flux, which in
combination with dissipative coupling to the mechanical bath, leads to
nonreciprocal transport of photons with 35dB of isolation. Additionally,
optical pumping with blue-detuned light manifests as a particle non-conserving
interaction between photons and phonons, resulting in directional optical
amplification of 12dB in the isolator through direction. These results indicate
the feasibility of utilizing optomechanical circuits to create a more general
class of nonreciprocal optical devices, and further, to enable novel
topological phases for both light and sound on a microchip.Comment: 18 pages, 8 figures, 4 appendice
Intepirdine as Adjunctive Therapy to Donepezil for Mild-To-Moderate Alzheimer’s Disease: A Randomized, Placebo-Controlled, Phase 3 Clinical Trial (Mindset)
Introduction: A previous phase 2b study supported the use of the 5-HT6 receptor antagonist intepirdine as adjunctive therapy to donepezil for Alzheimer\u27s disease (AD) dementia. A phase 3 study, MINDSET, was performed to test this hypothesis. Methods: MINDSET was a global, double-blind, randomized, placebo-controlled trial in 1315 mild-to-moderate AD dementia patients on stable donepezil. Patients received 35 mg/day intepirdine or placebo for 24 weeks. The co-primary endpoints were change from baseline to week 24 on the Alzheimer\u27s Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) and Alzheimer\u27s Disease Cooperative Study-Activities of Daily Living (ADCS-ADL). Results: There were no statistically significant differences between intepirdine and placebo groups (adjusted mean [95% confidence interval]) on the co-primary endpoints ADAS-Cog (−0.36 [−0.95, 0.22], P = 0.2249) and ADCS-ADL (−0.09 [−0.90, 0.72], P = 0.8260). Intepirdine demonstrated a favorable safety profile similar to placebo. Discussion: Intepirdine as adjunctive therapy to donepezil did not produce statistical improvement over placebo on cognition or activities of daily living in mild-to-moderate AD dementia patients
A Green's function approach to transmission of massless Dirac fermions in graphene through an array of random scatterers
We consider the transmission of massless Dirac fermions through an array of
short range scatterers which are modeled as randomly positioned -
function like potentials along the x-axis. We particularly discuss the
interplay between disorder-induced localization that is the hallmark of a
non-relativistic system and two important properties of such massless Dirac
fermions, namely, complete transmission at normal incidence and periodic
dependence of transmission coefficient on the strength of the barrier that
leads to a periodic resonant transmission. This leads to two different types of
conductance behavior as a function of the system size at the resonant and the
off-resonance strengths of the delta function potential. We explain this
behavior of the conductance in terms of the transmission through a pair of such
barriers using a Green's function based approach. The method helps to
understand such disordered transport in terms of well known optical phenomena
such as Fabry Perot resonances.Comment: 22 double spaced single column pages. 15 .eps figure
Genetic risk for schizophrenia and psychosis in Alzheimer disease
Psychotic symptoms, defined as the occurrence of delusions or hallucinations, are frequent in Alzheimer disease (AD), affecting ~40 to 60% of individuals with AD (AD with psychosis (AD+P)). In comparison with AD subjects without psychosis, AD+P subjects have more rapid cognitive decline and poor outcomes. Prior studies have estimated the heritability of psychosis in AD at 61%, but the underlying genetic sources of this risk are not known. We evaluated a Discovery Cohort of 2876 AD subjects with (N=1761) or without psychosis (N=1115). All subjects were genotyped using a custom genotyping array designed to evaluate single-nucleotide polymorphisms (SNPs) with evidence of genetic association with AD+P and include SNPs affecting or putatively affecting risk for schizophrenia and AD. Results were replicated in an independent cohort of 2194 AD subjects with (N=734) or without psychosis (N=1460). We found that AD+P is associated with polygenic risk for a set of novel loci and inversely associated with polygenic risk for schizophrenia. Among the biologic pathways identified by the associations of schizophrenia SNPs with AD+P are endosomal trafficking, autophagy and calcium channel signaling. To the best of our knowledge, these findings provide the first clear demonstration that AD+P is associated with common genetic variation. In addition, they provide an unbiased link between polygenic risk for schizophrenia and a lower risk of psychosis in AD. This provides an opportunity to leverage progress made in identifying the biologic effects of schizophrenia alleles to identify novel mechanisms protecting against more rapid cognitive decline and psychosis risk in AD
Recruitment of pre-dementia participants: main enrollment barriers in a longitudinal amyloid-PET study
Background: The mismatch between the limited availability versus the high demand of participants who are in the pre-dementia phase of Alzheimer’s disease (AD) is a bottleneck for clinical studies in AD. Nevertheless, potential enrollment barriers in the pre-dementia population are relatively under-reported. In a large European longitudinal biomarker study (the AMYPAD-PNHS), we investigated main enrollment barriers in individuals with no or mild symptoms recruited from research and clinical parent cohorts (PCs) of ongoing observational studies. Methods: Logistic regression was used to predict study refusal based on sex, age, education, global cognition (MMSE), family history of dementia, and number of prior study visits. Study refusal rates and categorized enrollment barriers were compared between PCs using chi-squared tests. Results: 535/1856 (28.8%) of the participants recruited from ongoing studies declined participation in the AMYPAD-PNHS. Only for participants recruited from clinical PCs (n = 243), a higher MMSE-score (β = − 0.22, OR = 0.80, p <.05), more prior study visits (β = − 0.93, OR = 0.40, p <.001), and positive family history of dementia (β = 2.08, OR = 8.02, p <.01) resulted in lower odds on study refusal. General study burden was the main enrollment barrier (36.1%), followed by amyloid-PET related burden (PCresearch = 27.4%, PCclinical = 9.0%, X 2 = 10.56, p =.001), and loss of research interest (PCclinical = 46.3%, PCresearch = 16.5%, X 2 = 32.34, p <.001). Conclusions: The enrollment rate for the AMYPAD-PNHS was relatively high, suggesting an advantage of recruitment via ongoing studies. In this observational cohort, study burden reduction and tailored strategies may potentially improve participant enrollment into trial readiness cohorts such as for phase-3 early anti-amyloid intervention trials. The AMYPAD-PNHS (EudraCT: 2018–002277-22) was approved by the ethical review board of the VU Medical Center (VUmc) as the Sponsor site and in every affiliated site
Investigating reliable amyloid accumulation in Centiloids: Results from the AMYPAD Prognostic and Natural History Study.
To support clinical trial designs focused on early interventions, our study determined reliable early amyloid-β (Aβ) accumulation based on Centiloids (CL) in pre-dementia populations. A total of 1032 participants from the Amyloid Imaging to Prevent Alzheimer's Disease-Prognostic and Natural History Study (AMYPAD-PNHS) and Insight46 who underwent [ F]flutemetamol, [ F]florbetaben or [ F]florbetapir amyloid-PET were included. A normative strategy was used to define reliable accumulation by estimating the 95 percentile of longitudinal measurements in sub-populations (N  = 101/750, N  = 35/382) expected to remain stable over time. The baseline CL threshold that optimally predicts future accumulation was investigated using precision-recall analyses. Accumulation rates were examined using linear mixed-effect models. Reliable accumulation in the PNHS was estimated to occur at >3.0 CL/year. Baseline CL of 16 [12,19] best predicted future Aβ-accumulators. Rates of amyloid accumulation were tracer-independent, lower for APOE ε4 non-carriers, and for subjects with higher levels of education. Our results support a 12-20 CL window for inclusion into early secondary prevention studies. Reliable accumulation definition warrants further investigations. [Abstract copyright: © 2024 The Authors. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.
- …